Australian researchers analyzed 206 international publications evaluating intensive care unit pneumonia prevention methods.
They found an average of 23.7 percent of patients receiving prolonged mechanical ventilation experienced VAP. For patients receiving topical antibiotics, an average of 38 percent developed VAP.
“The contextual effect of topical antibiotics is paradoxic, peculiar, potent, perfidious and potentially perilous,” researchers conclude.
More articles on HAIs:
C. diff meets its match in natural gut flora
Preventing SSIs: The sterile processing connection
Mission Hospital resumes elective surgeries after infection issue
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
